Ceramide synthesis and metabolism as a target for cancer therapy
- 5 January 2004
- journal article
- review article
- Published by Elsevier in Cancer Letters
- Vol. 206 (2) , 169-180
- https://doi.org/10.1016/j.canlet.2003.08.034
Abstract
No abstract availableKeywords
This publication has 77 references indexed in Scilit:
- Factor Associated With Neutral Sphingomyelinase Activation and Its Role in Cardiac Cell DeathCirculation Research, 2003
- Biochemical Properties of Mammalian Neutral Sphingomyelinase2 and Its Role in Sphingolipid MetabolismPublished by Elsevier ,2003
- Endothelial Apoptosis as the Primary Lesion Initiating Intestinal Radiation Damage in MiceScience, 2001
- Molecular Mechanisms of Ceramide-Mediated CD95 ClusteringBiochemical and Biophysical Research Communications, 2001
- Enzymes of Sphingolipid Metabolism: From Modular to Integrative SignalingBiochemistry, 2001
- Cloning and Expression of a Novel Lysophospholipase Which Structurally Resembles Lecithin Cholesterol AcyltransferaseBiochemical and Biophysical Research Communications, 1999
- Secretory Sphingomyelinase, a Product of the Acid Sphingomyelinase Gene, Can Hydrolyze Atherogenic Lipoproteins at Neutral pHJournal of Biological Chemistry, 1998
- Compartmentalized Production of Ceramide at the Cell SurfacePublished by Elsevier ,1995
- Ceramide synthase mediates daunorubicin-induced apoptosis: An alternative mechanism for generating death signalsCell, 1995
- Sphingomyelin and derivatives as cellular signalsProgress in Lipid Research, 1991